Today, Pulmonx Corp (NASDAQ: LUNG) Takes Center Stage

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Stocks Info

The company is listed on the NASDAQ and operates within the Medical Devices industry segment. The current market capitalization of Pulmonx Corp is $342.00M. A total of 0.84 million shares were traded on the day, compared to an average of 622.83K shares.

In the most recent transaction, Rose Geoffrey Beran sold 1,184 shares of LUNG for 7.49 per share on Apr 22 ’24. After the transaction, the CHIEF COMMERCIAL OFFICER now owns 306,684 company shares. In a previous transaction on Mar 22 ’24, Rose Geoffrey Beran sold 1,184 shares at 9.36 per share. LUNG shares that CHIEF COMMERCIAL OFFICER owns now total 307,868.

Among the insiders who sold shares, French Glendon E. III disposed of 6,954 shares on Mar 01 ’24 at a per-share price of $9.06. This resulted in the PRESIDENT AND CEO holding 1,116,758 shares of LUNG after the transaction. In another insider transaction, Lehman David Aaron sold 4,351 shares at $9.06 per share on Mar 01 ’24. Company shares held by the GENERAL COUNSEL now total 145,488.

It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, LUNG has a high of $14.84 and a low of $7.11.

Balance Sheet Annually/Quarterly

An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. LUNG’s latest balance sheet shows that the firm has $180.04M in Cash & Short Term Investments as of fiscal 2021. There were $26.46M in debt and $17.55M in liabilities at the time. Its Book Value Per Share was $2.85, while its Total Shareholder’s Equity was $193.24M.

Analysts Opinion

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for LUNG is Buy with a score of 5.00.

Most Popular

Related Posts